ReviewFrontiers in oncology2026

ERCC6L in human cancers: oncogenic functions, molecular mechanisms, and clinical implications as a prognostic biomarker and therapeutic target.

Lingyu Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.